Abstract:Objective To construct a prokaryotic expression vector in which the maximum level of rRTA-Trx fusion protein was attained with homogeneous,soluble,and full bioactive,and to prepare anti-rRTA monoclonal antibody(mAb) and establish sandwich ELISA for ricin detection.Methods A pair of RTA special primer was designed based on computer-aided design,RNA secondary structure,and also Escherichia coli partialism codon.RTA gene was cloned from PUC19/RA to pET32a(+) by PCR.Prokaryotic expression vector pET32a(+)/rRA/JM109 was eatablished and identified by double enzyme digestion and DNA sequencing.After induction with IPTG,the rRTA protein was obtained,and then purified by Ni2+-NTA resin column and evaluated by ELISA and Western blot assays.An anti-RTA mAb was obtained by using hybridoma technique and identified by Western blot assay.A sandwich ELISA for ricin detection was also established.Results a prokaryotic expression vector pET32a(+)/rRA/BL21 was constructed.Recombinant RTA proteins with high biological activity were successfully produced in the pET32a vector expression system.After purification with Ni2+-NTA resin column,the extraction showed a yield of approximately 10-20 mg/L.An anti-RTA mAb was obtained with hybridoma technique and specific ELISA screening.Western blotting showed that the mAb had specific binding ability to RTA in reduced SDS-PAGE.A sandwich ELISA for detects ricin was established with a ricin detection limit of 3.125 ng/mL.Conclusion rRTA,anti-RTA mAb,and a sandwich ELISA for ricin detection have practical use in biotherapy against carcinoma and in prophylaxis,diagnosis and therapeutics against bioterror attack of in the future.

The Preliminary Study on TRAP Polyclonal Antibodies

Cloning and Expression of TRAP in E.coli

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

C-terminus of TRAP in Staphylococcus Can Enhance the Activity of Lysozyme and Lysostaphin

A Novel Peptide Screened by Phage Display Can Mimic TRAP Antigen Epitope Against Staphylococcus Aureus Infections

Inhibition of Staphylococcus aureus pathogenesis in vitro and in vivo by RAP-binding peptides.

Preparation and Identification of Polyclonal Antibodies Against LPTS

The Preparation and Preliminary Application of the Epitope Peptide-Based Antibody Against TRIM22

Preparation and Identification of Rabbit Anti-human Pre-mRNA Splicing Protein Tra2β1 Antibody

[Prokaryotic Expression of Staphylococcus Aureus Clumping Factor B and Evaluation of the Antiserum-Mediated Opsonic Activity].

Preparation,Purification and Identification of Polyclonal Antibody Against STEAP4

The Production and Application of TRIP-1 Antibody

[Preparation and Application of Antibody Against Staphylococcal Enterotoxin C2].

Expression and purification of recombination ricin toxin A and its monoclonal antibody based sensitive ELISA

Preparation of polyclonal antibody against Stat3 and its application in the diagnosis of breast cancer

[Preparation and Identification of Monoclonal Antibody Against Repression and Activation Protein 1].

Potent Anti-Tumor Activity of CD45RA-targeting Hm3A4-Ranpirnase Against Myeloid Lineage Leukemias

Human monoclonal antibodies against Staphylococcus aureus A protein identified by high-throughput single-cell sequencing of phase I clinical volunteers' B cells

Identification of a Human Anti-Alpha-Toxin Monoclonal Antibody Against <i>Staphylococcus aureus</i> Infection

Prokaryotic expression and polyclonal antibody preparation of human novel gene CTRP4]

A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation